Anaptysbio ANAB Cash Flow Statement (2016-2026)

NASDAQ ANAB
$56.40 -1.06 (-1.84%)
As of: Sep 4, 2026 · 12:48 PM EDT
Reported Financials

Anaptysbio Quarterly Cash Flow Statement

Periods 41 quarters
Latest Mar 2026

Anaptysbio reported cash from operations of -$25.92M and free cash flow of -$25.94M for the quarter ended Mar 2026, down 142.2% year over year. This cash flow statement covers 41 quarters of results from Mar 2016 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income
-0.43M-6.70M-31.09M-31.41M-26.69M-27.37M-22.13M-39.91M-39.84M-37.31M-7.85M-43.94M-46.66M-32.85M8.58M-39.33M-38.63M15.11M52.52M-52.88M
Share-based CompensationStock Comp.
17.37M7.74M2.90M3.00M6.68M8.86M2.90M3.00M8.11M10.13M7.54M8.19M8.18M9.17M9.24M9.16M8.51M14.22M
Deferred Taxes
-3.54M
Gains from Investment SecuritiesGains Investment
Cash from OperationsCash from Ops.
9.59M-7.01M-25.30M-21.01M-24.15M-17.75M-10.69M-24.57M-25.41M-36.47M-34.35M-37.25M-21.32M-10.09M-66.67M-10.70M-40.24M-27.36M98.00M-25.92M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.62M0.50M0.22M0.41M0.41M0.42M0.42M0.43M0.42M0.43M0.44M0.44M0.44M0.45M0.46M0.46M0.46M0.47M0.47M0.48M
Depreciation & Amortization (CF)Dep. & Amort.
0.16M0.17M0.17M0.16M0.16M0.17M0.18M0.17M0.16M0.16M0.17M0.16M0.15M0.14M0.14M0.15M0.14M0.14M0.13M0.13M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp.
5.75M-0.19M-5.32M3.54M0.07M1.26M4.83M8.53M6.61M-2.70M-1.50M-5.17M8.02M3.36M-40.05M-24.03M-22.32M-18.56M-22.41M-17.82M
Change in TaxesChange Taxes
Investing Activities
Capital ExpendituresCapex
0.86M0.17M0.01M0.06M0.08M0.05M0.17M0.17M0.19M0.16M0.28M0.03M0.03M0.04M0.26M0.04M0.04M0.01M0.00M0.02M
Change in Acquisitions & DivestmentsChange Acquisitions
42.32M27.74M25.50M9.62M101.40M147.75M149.25M134.13M98.74M100.84M115.77M127.64M146.74M110.00M91.75M137.43M90.65M122.95M73.50M35.00M
Cash from Investing ActivitiesCash from Investing
37.96M10.84M-66.69M-312.91M-71.00M-32.43M21.50M85.40M-20.45M30.64M49.18M68.62M-2.44M58.62M-29.40M14.85M36.40M103.28M73.50M34.98M
Financing Activities
Other financing activitiesOther financing
0.55M0.24M
Cash from Financing ActivitiesCash from Financing
0.55M0.24M251.34M4.61M0.43M37.03M1.95M-37.57M-13.49M-3.07M-5.16M-13.63M41.89M71.23M27.57M-28.59M-50.50M-10.39M-43.13M1.21M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.76M0.67M
Net Equity Issued and RepurchasedNet Equity Issued
0.55M0.24M1.59M4.84M0.86M2.70M3.42M1.26M0.78M0.16M0.26M0.81M0.98M0.56M0.29M1.42M0.34M12.21M14.02M
Additional items
Change in Cash
48.11M4.07M159.34M-329.32M-94.71M-13.15M12.76M23.25M-59.36M-8.91M9.67M17.73M18.13M119.76M-68.50M-24.44M-54.34M65.53M128.36M10.27M
Free Cash FlowFCF
8.73M-7.18M-25.32M-21.07M-24.23M-17.80M-10.86M-24.74M-25.60M-36.64M-34.63M-37.28M-21.36M-10.12M-66.94M-10.73M-40.28M-27.37M98.00M-25.94M
Net Cash FlowNCF
48.11M4.07M159.34M-329.32M-94.71M-13.15M12.76M23.25M-59.36M-8.91M9.67M17.73M18.13M119.76M-68.50M-24.44M-54.34M65.53M128.36M10.27M